1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Small Molecule Drug Discovery Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Small Molecule Drug Discovery Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Small Molecule Drug Discovery Market Regional Analysis
6.2 Asia Pacific Small Molecule Drug Discovery Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific Small Molecule Drug Discovery Market Forecast Analysis
7. Asia Pacific Small Molecule Drug Discovery Market Analysis – by Therapeutic Area
7.1 Oncology
- 7.1.1 Overview
- 7.1.2 Oncology: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Central Nervous System
- 7.2.1 Overview
- 7.2.2 Central Nervous System: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Cardiovascular
- 7.3.1 Overview
- 7.3.2 Cardiovascular: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Respiratory
- 7.4.1 Overview
- 7.4.2 Respiratory: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Orthopedics
- 7.5.1 Overview
- 7.5.2 Orthopedics: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Immunology
- 7.6.1 Overview
- 7.6.2 Immunology: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Rare Diseases
- 7.7.1 Overview
- 7.7.2 Rare Diseases: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.8 Other Therapeutic Areas
- 7.8.1 Overview
- 7.8.2 Other Therapeutic Areas: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Asia Pacific Small Molecule Drug Discovery Market Analysis – by Process/Phase
8.1 Target Discovery
- 8.1.1 Overview
- 8.1.2 Target Discovery: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Target Validation
- 8.2.1 Overview
- 8.2.2 Target Validation: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Lead Generation and Refinement
- 8.3.1 Overview
- 8.3.2 Lead Generation and Refinement: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Preclinical Development
- 8.4.1 Overview
- 8.4.2 Preclinical Development: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Asia Pacific Small Molecule Drug Discovery Market – Asia-Pacific Analysis
9.1 Overview
9.2 Asia-Pacific
- 9.2.1 Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 Asia Pacific Small Molecule Drug Discovery Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 China:
Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 China: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
- 9.2.1.1.2 China: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase
- 9.2.1.2 India:
Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 India: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
- 9.2.1.2.2 India: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase
- 9.2.1.3 Japan:
Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 Japan: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
- 9.2.1.3.2 Japan: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase
- 9.2.1.4 Australia:
Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Australia: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
- 9.2.1.4.2 Australia: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase
- 9.2.1.5 Rest of Asia-Pacific :
Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
- 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Pfizer Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GlaxoSmithKline plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Johnson & Johnson Services, Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Gilead Sciences, Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations